Dr. Moody studies cardiac amyloidosis, a serious condition that can affect heart function, particularly in patients with transthyretin cardiac amyloidosis (ATTR-CM). He is actively involved in researching how artificial intelligence can enhance the diagnosis of this condition using echocardiography, which is an ultrasound technique used to visualize the heart. His studies also address the monitoring and treatment outcomes of patients undergoing liver transplantation, examining their risks for serious heart problems post-surgery. Additionally, he investigates heart health in relation to kidney function and examines the predictors of sudden cardiac events in patients with implanted heart devices.
Key findings
An AI-based echocardiography scoring system achieved 79.5% accuracy in diagnosing cardiac amyloidosis and a deep-learning model reached 96.2% accuracy.
Among over 10,200 liver transplant patients, 2.6% experienced major adverse cardiovascular events (MACE) within the first year, highlighting the need for better heart health management post-transplant.
A 5% decrease in a key heart measurement over one year corresponded to a 41% increased risk of death in patients with transthyretin cardiac amyloidosis.
Patients with a shorter distance in a 6-minute walking test had a 2.2 times higher risk of dying compared to those who walked further, showcasing the test's importance in assessing risk.
In heart transplant cases for ATTR-CM, 90% of patients were alive five years after surgery without recurrence of amyloid in their new hearts.
Frequently asked questions
Does Dr. Moody study cardiac amyloidosis?
Yes, Dr. Moody focuses extensively on cardiac amyloidosis, particularly transthyretin cardiac amyloidosis.
What treatments has Dr. Moody researched?
He has researched heart transplants and the use of artificial intelligence to improve the diagnosis and monitoring of heart conditions.
Is Dr. Moody's work relevant to liver transplant patients?
Yes, his research assesses the risks of heart problems in liver transplant patients and their long-term health outcomes.
How does Dr. Moody use artificial intelligence in his research?
He utilizes AI to enhance the accuracy of diagnosing and monitoring cardiac amyloidosis through echocardiographic assessments.
What findings does Dr. Moody have regarding patient monitoring?
He has found that simple tests like the 6-minute walk test can significantly predict patient outcomes in conditions like transthyretin cardiac amyloidosis.
Publications in plain English
Case of sarcoidosis and coronary artery disease presenting with heart failure: highlighting the benefits of repatriation to Role 4 medical facilities in complex cases.
2026
BMJ military health
Zhan R, Chamley R, Moody W, Aswathi R, Williams A +1 more
Major adverse cardiovascular events after liver transplantation: a population cohort analysis of English transplant centres.
2026
EClinicalMedicine
Evison F, Gallier S, Malik F, Stephens C, Ferro CJ +4 more
Plain English This study looked at the occurrence of serious heart problems, known as major adverse cardiovascular events (MACE), in patients who had liver transplants in England from 2002 to 2023. Out of over 10,200 liver transplant patients, 268 (or 2.6%) experienced MACE in the first year, with strokes being the most common issue. Although serious heart problems are rare after liver transplants, patients who do experience them in their first year are more likely to have lower survival rates in the long term, which highlights the need for better management of heart health in these patients.
Who this helps: This helps liver transplant patients and their doctors.
Diagnosis of Cardiac Amyloidosis on Echocardiography Using Artificial Intelligence.
2026
Circulation. Cardiovascular imaging
Ioannou A, Khouri MG, Kitai T, Vemulapalli S, Hung CL +20 more
Plain English This study looked at how well artificial intelligence (AI) can help doctors diagnose cardiac amyloidosis (CA) using echocardiograms, which are heart ultrasound images. They found that an AI method achieved an accuracy of 79.5% when distinguishing CA in the U.S. cohort, while a more advanced deep-learning model reached an impressive 96.2% accuracy in controlled settings. This improvement is significant since accurate diagnosis can lead to better treatment and management of CA, a condition that can be easily confused with other heart diseases.
Who this helps: Patients with cardiac amyloidosis and their doctors will benefit from more accurate and efficient diagnoses.
Kidney Outcomes in Transthyretin Amyloid Cardiomyopathy.
2025
JAMA cardiology
Ioannou A, Razvi Y, Porcari A, Rauf MU, Martinez-Naharro A +16 more
Plain English This study looked at patients with transthyretin amyloid cardiomyopathy (ATTR-CM) to see how changes in kidney function relate to survival. Among over 2,000 patients, about 24% experienced a significant decline in kidney function, and this decline was linked to a 1.7 times higher risk of dying. The findings indicate that monitoring kidney function can provide important insights into disease progression and help doctors make better treatment decisions.
Who this helps: This helps patients with ATTR-CM and their doctors.
Chest Pain With Significantly Elevated Troponins: Be Wary of False Positives.
2025
Cureus
Narayanan TT, Naneishvili T, Moody W, Townend J, Ludman P
Plain English This study looked at a 45-year-old woman who had chest pain and very high levels of troponin, which is a protein often linked to heart issues. Despite her troponin levels being extremely high, all tests, including heart scans and procedures, showed no heart problems. The research highlights that high troponin levels can sometimes give misleading results, which is important for making accurate heart-related diagnoses.
Who this helps: This helps doctors ensure they do not misdiagnose patients with heart issues based on troponin levels alone.
British Society of Echocardiography guideline for the transthoracic echocardiographic assessment of adult patients with obstructive hypertrophic cardiomyopathy receiving myosin-inhibitor therapy.
2025
Echo research and practice
Culshaw CM, Augustine D, Coats CJ, Andrade I, Pearce K +9 more
Artificial intelligence-based echocardiographic assessment for monitoring disease progression in transthyretin cardiac amyloidosis.
2025
European journal of heart failure
Venneri L, Aimo A, Porcari A, Sezer I, Ioannou A +19 more
Plain English This research studied how an artificial intelligence tool could help monitor heart function in patients with transthyretin cardiac amyloidosis (ATTR-CM), a condition that affects the heart and can lead to serious health problems. The study found that a 5% or greater decrease in a specific heart measurement (LVOT-VTI) over one year was linked to a higher risk of death, with a significant 41% increased risk of mortality for those with this decrease. Monitoring this measurement could help doctors decide when to change or escalate treatment, potentially improving patient outcomes.
Who this helps: Patients with transthyretin cardiac amyloidosis and their doctors.
Giant left sinus of Valsalva aneurysm as a rare cause of acute myocardial infarction: a case report.
2024
European heart journal. Case reports
Maqableh GM, Yuan M, Moody W, Baig S, Khan SQ
Plain English This study looked at a rare condition called a left sinus of Valsalva aneurysm (SVA) and how it can lead to a heart attack, specifically in a 55-year-old man who was hospitalized with heart failure and an unusual type of heart attack. The aneurysm measured nearly 10 centimeters and was pressing on important heart arteries, which contributed to his condition. Understanding and diagnosing this rare problem is crucial because it can help doctors find the best treatment options and prevent serious outcomes.
Who this helps: This helps patients with heart conditions and their doctors.
Disruption of CD47-SIRPα signaling restores inflammatory function in tumor-associated myeloid-derived suppressor cells.
2024
iScience
Zimarino C, Moody W, Davidson SE, Munir H, Shields JD
Plain English This study investigated how a specific signaling pathway, CD47-SIRPα, affects immune cells in cancer, particularly myeloid-derived suppressor cells (MDSCs) that can suppress the immune response to tumors. The researchers found that blocking this signaling pathway improved the immune cells' ability to fight cancer by restoring their function, leading to increased T-cell activity and slower tumor growth in mice. This research is important because it suggests that combining treatments that target these immune cells with existing therapies could make cancer treatment more effective.
Who this helps: This benefits cancer patients by potentially improving their treatment outcomes.
Prognostic Value of a 6-Minute Walk Test in Patients With Transthyretin Cardiac Amyloidosis.
2024
Journal of the American College of Cardiology
Ioannou A, Fumagalli C, Razvi Y, Porcari A, Rauf MU +12 more
Plain English This study examined how the 6-minute walk test (6MWT) can predict outcomes for patients with transthyretin cardiac amyloidosis (ATTR-CA), a type of heart disease. It analyzed data from over 2,100 patients, finding that those who walked less than 350 meters in 6 minutes had a 2.2 times greater risk of dying compared to those who walked further. Additionally, significant declines in walking distance over one year were linked to a higher risk of mortality, highlighting the test's value in assessing patient risk.
Who this helps: This research benefits patients with ATTR-CA and their doctors by providing important insights on how to measure and manage their condition more effectively.
Mucocutaneous adverse events to immune checkpoint inhibitors.
2023
Frontiers in allergy
Muhaj F, Karri PV, Moody W, Brown A, Patel AB
Plain English This study examined skin-related side effects caused by immune checkpoint inhibitors (ICIs), a type of cancer treatment. Researchers found that while less than 3% of these skin reactions were severe (grade 3 or higher), they can significantly affect a patient's quality of life and may lead to interruptions in important cancer treatments. Understanding and managing these skin issues is essential for keeping patients on their immunotherapy.
Who this helps: This benefits cancer patients receiving immunotherapy and their doctors.
The atrial and ventricular myocardial proteome of end-stage lamin heart disease.
2023
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology
Topriceanu CC, Alfarih M, Hughes AD, Shiwani H, Chan F +11 more
Plain English This study looked at the heart tissue of patients with end-stage lamin heart disease, a condition caused by problems with a protein called lamin A/C, and compared it to those with ischemic dilated cardiomyopathy (ICM), a common heart disease. They found that a total of 990 proteins were found in different amounts between the two groups, with the left atrium showing the biggest changes—specifically, lamin A/C was less common while other proteins like carbonic anhydrase 3 were more abundant in all the lamin heart disease tissues. This is important because it could help us understand how lamin heart disease affects the heart differently from other types of heart disease, potentially guiding better treatments.
Who this helps: This helps patients with lamin heart disease and their doctors.
Myocardial Fibrosis Predicts Ventricular Arrhythmias and Sudden Death After Cardiac Electronic Device Implantation.
2022
Journal of the American College of Cardiology
Leyva F, Zegard A, Okafor O, Foley P, Umar F +10 more
Plain English This study looked at how heart tissue damage, known as myocardial fibrosis, can predict serious heart problems like sudden cardiac death and dangerous heart rhythms in patients who have devices implanted to help their hearts. Among 700 patients followed for about 7 years, 27 (3.85%) experienced sudden cardiac death and 121 (17.3%) had dangerous heart rhythms. The findings show that patients with myocardial fibrosis were much more likely to experience these issues, with a specific type of tissue damage (gray zone fibrosis) greatly increasing that risk.
Who this helps: This information helps doctors identify which patients with heart devices are at higher risk for serious complications.
Right ventricular function and long-term clinical outcomes after cardiac resynchronization therapy: A cardiovascular magnetic resonance study.
2022
Pacing and clinical electrophysiology : PACE
Zegard A, Okafor O, Moody W, Marshall H, Qiu T +3 more
Plain English This study looked at how the function of the right side of the heart affects the long-term results for patients who receive cardiac resynchronization therapy (CRT). They specifically examined 243 patients over about six years and found that changes in the right heart function did not predict death or other serious heart issues after the treatment. This matters because it suggests that factors related to the right side of the heart shouldn't be used to decide who should receive CRT.
Who this helps: This helps doctors determine the suitability of CRT for their patients without worrying about the right heart's function.
Cardiac transplantation in transthyretin amyloid cardiomyopathy: Outcomes from three decades of tertiary center experience.
2022
Frontiers in cardiovascular medicine
Razvi Y, Porcari A, Di Nora C, Patel RK, Ioannou A +25 more
Plain English This study looked at the outcomes of heart transplants for patients with a condition called transthyretin cardiac amyloidosis (ATTR-CM) over 30 years at two medical centers. They found that out of 14 patients who received heart transplants, 90% were still alive five years later, and none had a recurrence of amyloid in their new hearts. This is important because it shows that cardiac transplantation is a safe and effective treatment for ATTR-CM, greatly improving patients' chances of survival compared to those who did not have a transplant.
Who this helps: Patients with transthyretin cardiac amyloidosis.
Acute Presentation of Structural Valve Degeneration in a Transcatheter Heart Valve (Sapien XT) at 7.5 Years; Successful Redo TAVR With a Sapien 3 Ultra.
2021
CJC open
Doshi SN, Nadir A, Moody W, Townend JN
Plain English In this research, a 77-year-old man developed severe heart failure due to an issue with his transcatheter heart valve 7.5 years after it was implanted. The problem, called leaflet prolapse, occurred without clear warning signs in previous heart scans, and the study found that replacing the valve can be done safely and effectively with a new device. This is important because it shows that problems can arise unexpectedly with heart valves, and doctors can successfully replace them to help patients regain good heart function.
Who this helps: Patients who have received a transcatheter heart valve and may face future complications.
Impact of methodology and the use of allometric scaling on the echocardiographic assessment of the aortic root and arch: a study by the Research and Audit Sub-Committee of the British Society of Echocardiography.
2014
Echo research and practice
Oxborough D, Ghani S, Harkness A, Lloyd G, Moody W +9 more
Plain English This study looked at how different methods of ultrasound imaging affect the measurement of the aortic root (part of the heart) in 248 healthy people. It found that measurements were usually larger when taken at the peak of heart activity (systole), especially with one specific technique called the leading edge method. The research also showed that adjusting these measurements to account for body size (using a formula) helped create a standard that applies regardless of a person's size, age, or gender.
Who this helps: This benefits doctors by providing clearer guidelines for assessing heart size in different patients.
Induction of chromosome changes by metal compounds in cultured CHO cells.
1991
Toxicology letters
Howard W, Leonard B, Moody W, Kochhar TS
Plain English This study looked at how four metal salts—cadmium chloride, nickel chloride, chromium trioxide, and mercury chloride—affect chromosome changes in lab-grown Chinese hamster ovary cells. The researchers found that higher doses of these metals led to more chromosome defects, with abnormal changes rising significantly. Understanding these effects is important for quickly identifying harmful metals that could pose risks to health.
Who this helps: This helps patients and public health officials by highlighting potentially dangerous substances to avoid.
Rapidly activating hydrogen ion currents in perfused neurones of the snail, Lymnaea stagnalis.
1984
The Journal of physiology
Byerly L, Meech R, Moody W
Plain English This study focused on the nerve cells of the pond snail, Lymnaea stagnalis, to investigate how hydrogen ions (H+) flow in and out of these cells. Researchers found that certain conditions, like high internal pH or low external pH, reduced the flow of H+ ions, while specific substances like cadmium ions also affected this flow. Understanding how H+ currents operate helps to clarify how these cells deal with acid buildup during nerve signaling.
Who this helps: This benefits researchers and neuroscientists studying nerve function in snails and potentially in other organisms.
Appearance of calcium action potentials in crayfish slow muscle fibres under conditions of low intracellular pH.
1980
The Journal of physiology
Moody W
Plain English This study looked at how low pH levels inside crayfish muscle cells affect their ability to generate electrical signals called calcium action potentials. When the internal pH dropped to between 6.4 and 6.5, the cells started producing these strong signals instead of their usual weaker responses. This change is important because it shows how shifts in pH can impact muscle cell function and might help us understand similar processes in other muscle types.
Who this helps: This helps researchers and doctors studying muscle function and related disorders.
Electrophysiological properties of onion guard cells.
1978
Planta
Moody W, Zelger E
Plain English This study looked at the electrical activity of guard cells in onion plants, which help control water loss by regulating openings on leaves. Researchers measured the electrical charge across these cells, finding that healthy cells averaged a charge of about -72 millivolts, while partially digested cells showed a lesser charge of about -39 millivolts. These findings are important because they suggest how light affects these cells, influencing their ability to control water loss through small openings called stomata.
Who this helps: This helps researchers and farmers understand plant behavior related to water regulation.
Blocking effects of barium and hydrogen ions on the potassium current during anomalous rectification in the starfish egg.
1978
The Journal of physiology
Hagiwara S, Miyazaki S, Moody W, Patlak J
Plain English This study looked at how certain ions, specifically barium (Ba2+) and hydrogen (H+), affect the flow of potassium (K) ions in starfish eggs under specific conditions. Researchers found that even a small amount of Ba2+ can significantly lower the inward K current, and this blocking action shows a clear pattern based on the egg membrane's electrical charge. Understanding these effects is important because it provides insight into how potassium channels work, which could inform future research on cellular functions.
Who this helps: This helps researchers studying ion channels and their role in cellular activity.
Adam Ioannou Lucia Venneri Yousuf Razvi Aldostefano Porcari Ana Martinez-Naharro Helen Lachmann Julian D Gillmore Marianna Fontana Carol Whelan Muhammad U Rauf
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.